Antimalarial drugs appear to follow a typical pattern, with early effectiveness eventually limited by the emergence of drug resistance. A report in the Journal of Molecular Diagnostics describes a new assay using whole blood that simplifies the genetic analysis of malarial parasites by completely eliminating processing steps. This provides rapid access to critical information associated with resistance to antimalarials at the point of care, avoiding the time, expense, and effort of having the sample sent to a central laboratory and allowing clinicians to quickly re-evaluate treatment options.
* This article was originally published here
